# A Multicenter, Open-label Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-6914 Injection in Participants With Prostate Cancer

> **NCT07735377** · PHASE1 · RECRUITING · sponsor: **Suzhou Suncadia Biopharmaceuticals Co., Ltd.** · enrollment: 118 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** SHR-6914

## Key facts

- **NCT ID:** NCT07735377
- **Lead sponsor:** Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-26
- **Primary completion:** 2026-12
- **Final completion:** 2028-08
- **Target enrollment:** 118 (ESTIMATED)
- **Last updated:** 2026-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07735377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07735377, "A Multicenter, Open-label Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-6914 Injection in Participants With Prostate Cancer". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07735377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*